black forest glp 1 plot from meta-analysis models of GLP-1 RA's impact on (a) HbA1c... Impact of GLP-1 receptor agonists

Employers can't shirk responsibility for novel weight loss drugs forever, executives argued at a recent Newsweek event.

Learn how GLP-1s, GIPs, and newer combo drugs work, and whats currently FDA-approved.

Understand about the investigational Alluvi Retatrutide 40 mg injection a GLP-1 + GIP + Glucagon triple-agonist studied for obesity

However, the drugs alterations in gut motility may account for many of their commonly reported adverse effects including nausea, vomiting, early satiety, dyspepsia, and bowel habit changes

Shocking Truth: Compounded GLP-1s on Groupon pose serious health risks

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.